Edition:
United Kingdom

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

19.92USD
18 Oct 2018
Change (% chg)

$0.22 (+1.12%)
Prev Close
$19.70
Open
$19.59
Day's High
$19.92
Day's Low
$19.53
Volume
3,250
Avg. Vol
22,703
52-wk High
$23.81
52-wk Low
$7.74

Chart for

About

KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The Company has developed a portfolio of small molecule plasma kallikrein... (more)

Overall

Beta: --
Market Cap(Mil.): $70.42
Shares Outstanding(Mil.): 9.71
Dividend: --
Yield (%): --

Financials

  KALV.OQ Industry Sector
P/E (TTM): -- 30.92 33.69
EPS (TTM): -3.21 -- --
ROI: -60.80 14.76 14.30
ROE: -61.05 16.26 16.03

Earnings vs. Estimates